Parametric Portfolio Associates’s Innoviva INVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $8.04M | Buy |
415,677
+58,859
| +16% | +$1.05M | ﹤0.01% | 1526 |
|
|
2021
Q4 | $6.16M | Buy |
356,818
+16,153
| +5% | +$275K | ﹤0.01% | 1714 |
|
|
2021
Q3 | $5.69M | Buy |
340,665
+34,529
| +11% | +$517K | ﹤0.01% | 1738 |
|
|
2021
Q2 | $4.11M | Buy |
306,136
+34,391
| +13% | +$430K | ﹤0.01% | 1974 |
|
|
2021
Q1 | $3.25M | Sell |
271,745
-45,675
| -14% | -$552K | ﹤0.01% | 2464 |
|
|
2020
Q4 | $3.93M | Sell |
317,420
-35,898
| -10% | -$387K | ﹤0.01% | 2226 |
|
|
2020
Q3 | $3.69M | Buy |
353,318
+1,888
| +0.5% | +$24K | ﹤0.01% | 2104 |
|
|
2020
Q2 | $4.91M | Buy |
351,430
+16,717
| +5% | +$227K | ﹤0.01% | 1891 |
|
|
2020
Q1 | $3.94M | Buy |
334,713
+55,368
| +20% | +$732K | ﹤0.01% | 1918 |
|
|
2019
Q4 | $3.96M | Buy |
279,345
+57,501
| +26% | +$705K | ﹤0.01% | 2225 |
|
|
2019
Q3 | $2.34M | Sell |
221,844
-54,892
| -20% | -$656K | ﹤0.01% | 2551 |
|
|
2019
Q2 | $4.03M | Buy |
276,736
+30,272
| +12% | +$429K | ﹤0.01% | 2162 |
|
|
2019
Q1 | $3.46M | Sell |
246,464
-9,747
| -4% | -$158K | ﹤0.01% | 2267 |
|
|
2018
Q4 | $4.47M | Buy |
256,211
+37,683
| +17% | +$612K | ﹤0.01% | 1986 |
|
|
2018
Q3 | $3.33M | Buy |
218,528
+11,499
| +6% | +$166K | ﹤0.01% | 2334 |
|
|
2018
Q2 | $2.86M | Sell |
207,029
-81,828
| -28% | -$1.23M | ﹤0.01% | 2416 |
|
|
2018
Q1 | $4.82M | Sell |
288,857
-1,124
| -0.4% | -$17.3K | ﹤0.01% | 1930 |
|
|
2017
Q4 | $4.12M | Buy |
289,981
+91,377
| +46% | +$1.22M | ﹤0.01% | 2064 |
|
|
2017
Q3 | $2.8M | Buy |
198,604
+63,478
| +47% | +$839K | ﹤0.01% | 2339 |
|
|
2017
Q2 | $1.73M | Buy |
135,126
+4,219
| +3% | +$52.9K | ﹤0.01% | 2643 |
|
|
2017
Q1 | $1.81M | Buy |
130,907
+34,534
| +36% | +$407K | ﹤0.01% | 2511 |
|
|
2016
Q4 | $1.03M | Buy |
96,373
+3,879
| +4% | +$40.7K | ﹤0.01% | 2812 |
|
|
2016
Q3 | $1.02M | Sell |
92,494
-1,246
| -1% | -$14.5K | ﹤0.01% | 2797 |
|
|
2016
Q2 | $987K | Sell |
93,740
-13,985
| -13% | -$165K | ﹤0.01% | 2842 |
|
|
2016
Q1 | $1.36M | Buy |
107,725
+5,875
| +6% | +$64.5K | ﹤0.01% | 2694 |
|
|
2015
Q4 | $1.07M | Buy |
101,850
+61,802
| +154% | +$568K | ﹤0.01% | 2722 |
|
|
2015
Q3 | $288K | Buy |
40,048
+5,979
| +18% | +$81.3K | ﹤0.01% | 2982 |
|
|
2015
Q2 | $616K | Buy |
34,069
+1,430
| +4% | +$24.6K | ﹤0.01% | 3140 |
|
|
2015
Q1 | $513K | Buy |
32,639
+19,722
| +153% | +$298K | ﹤0.01% | 3248 |
|
|
2014
Q4 | $183K | Sell |
12,917
-453
| -3% | -$6.81K | ﹤0.01% | 3801 |
|
|
2014
Q3 | $228K | Sell |
13,370
-8,714
| -39% | -$200K | ﹤0.01% | 3571 |
|
|
2014
Q2 | $658K | Buy |
22,084
+3,468
| +19% | +$83.2K | ﹤0.01% | 3031 |
|
|
2014
Q1 | $464K | Buy |
18,616
+79
| +0.4% | +$2.31K | ﹤0.01% | 3218 |
|
|
2013
Q4 | $533K | Sell |
18,537
-2,651
| -13% | -$77.5K | ﹤0.01% | 3122 |
|
|
2013
Q3 | $698K | Buy |
21,188
+977
| +5% | +$30.4K | ﹤0.01% | 2856 |
|
|
2013
Q2 | $627K | Buy |
+20,211
| New | +$542K | ﹤0.01% | 2794 |
|
Other funds holding INVA
SCM
PI
Parametric Portfolio Associates's INVA Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Innoviva (INVA) stake by 16% in Q1 2022, buying an estimated $1.05M and bringing the position to 415,677 shares worth $8.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1526.
Parametric Portfolio Associates first reported a position in INVA in Q2 2013 and has held it in 36 quarters since. 236 funds tracked by Wall St. Rank hold INVA as of Q1 2022.
- Parametric Portfolio Associates held 415,677 shares of Innoviva worth $8.04M as of Q1 2022.
- Parametric Portfolio Associates bought 58,859 Innoviva shares in Q1 2022, an estimated $1.05M.
- Innoviva made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1526 holding.
- Parametric Portfolio Associates first reported a position in Innoviva in Q2 2013 and has held it in 36 quarters since.
- 236 funds tracked by Wall St. Rank held Innoviva as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.